Financials in USD. Standardized financial statements.
A compact view of how Firefly Neuroscience, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue? | $1.14M | $108,000 | $498,000 | $0 | $32,000 | $13.90M |
| Revenue Growth? | +957.4% | -78.3% | 0.0% | -100.0% | -99.8% | 0.0% |
| Cost of Revenue? | $497,000 | $67,000 | $0 | $0 | $0 | $11.69M |
| Gross Profit? | $645,000 | $41,000 | $498,000 | $0 | $32,000 | $2.21M |
| Gross Margin? | +56.5% | +38.0% | +100.0% | 0.0% | +100.0% | +15.9% |
| Operating Expenses? | $9.25M | $9.22M | $3.58M | $3.33M | $4.69M | $1.80M |
| Operating Income? | -$8.61M | -$9.18M | -$3.08M | -$3.33M | -$4.65M | $411,848 |
| EBITDA? | -$19.55M | -$10.32M | -$2.58M | -$3.20M | -$3.82M | $425,440 |
| Income Before Tax | -$19.88M | -$10.46M | -$2.60M | -$3.79M | -$4.38M | $413,379 |
| Income Tax Expense | $5,000 | $2,000 | $1,000 | $0 | $0 | $0 |
| Net Income? | -$19.88M | -$10.46M | -$2.60M | -$3.79M | -$4.38M | $413,379 |
| EPS? | $-1.86 | $-1.60 | $-0.33 | $-0.48 | $-0.56 | $0.05 |
| Diluted EPS? | $-1.82 | $-1.60 | $-0.33 | $-0.48 | $-0.56 | $0.05 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality